Literature DB >> 9150428

Tissue-specific expression of pancreatic-type RNases and RNase inhibitor in humans.

J Futami1, Y Tsushima, Y Murato, H Tada, J Sasaki, M Seno, H Yamada.   

Abstract

The tissue-specific expression of five human pancreatic-type RNases and RNase inhibitor was analyzed by Northern hybridization against poly(A)+ RNA prepared from 16 normal tissues. The widespread expression of RNase 1 was observed in almost all of the tissues. RNase 4 and angiogenin showed a similar distribution of expression abundantly present in the liver. This suggested the identity of the cell types producing these two molecules. However, no relativity appeared to be present between the vascularization of the tissues and the angiogenin expression. A narrow range of expression of the eosinophil-derived neurotoxin gene was observed. This localization seems related to the phagocytic cells in the tissues. The undetectable level of the eosinophil cationic protein mRNA in normal tissues suggests that the differentiation of eosinophils, triggered by inflammation and/or atopy, is required. The expression of RNase inhibitor was found to be ubiquitous. The regulatory function of inhibitor against RNases in the cell should be considered in studying the physiological significance of the pancreatic-type RNase family.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9150428     DOI: 10.1089/dna.1997.16.413

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  34 in total

1.  RNase 8, a novel RNase A superfamily ribonuclease expressed uniquely in placenta.

Authors:  Jianzhi Zhang; Kimberly D Dyer; Helene F Rosenberg
Journal:  Nucleic Acids Res       Date:  2002-03-01       Impact factor: 16.971

2.  Lack of detection of influenza genes in archived formalin-fixed, paraffin wax-embedded brain samples of encephalitis lethargica patients from 1916 to 1920.

Authors:  K C Lo; J F Geddes; R S Daniels; J S Oxford
Journal:  Virchows Arch       Date:  2003-04-15       Impact factor: 4.064

Review 3.  Ribonuclease inhibitor: structure and function.

Authors:  Kimberly A Dickson; Marcia C Haigis; Ronald T Raines
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2005

4.  Transcription of angiogenin and ribonuclease 4 is regulated by RNA polymerase III elements and a CCCTC binding factor (CTCF)-dependent intragenic chromatin loop.

Authors:  Jinghao Sheng; Chi Luo; Yuxiang Jiang; Philip W Hinds; Zhengping Xu; Guo-fu Hu
Journal:  J Biol Chem       Date:  2014-03-21       Impact factor: 5.157

5.  Ribonuclease 4 protects neuron degeneration by promoting angiogenesis, neurogenesis, and neuronal survival under stress.

Authors:  Shuping Li; Jinghao Sheng; Jamie K Hu; Wenhao Yu; Hiroko Kishikawa; Miaofen G Hu; Kaori Shima; David Wu; Zhengping Xu; Winnie Xin; Katherine B Sims; John E Landers; Robert H Brown; Guo-fu Hu
Journal:  Angiogenesis       Date:  2012-11-10       Impact factor: 9.596

6.  Overexpression of ribonuclease inhibitor defines good prognosis and suppresses proliferation and metastasis in human colorectal cancer cells via PI3K/AKT pathway.

Authors:  Y Tang; P Liu; Y Tian; Y Xu; F Ren; X Cui; J Fan
Journal:  Clin Transl Oncol       Date:  2014-09-26       Impact factor: 3.405

7.  Factors That Influence the Quality of RNA From the Pancreas of Organ Donors.

Authors:  Tiffany Philips; Irina Kusmartseva; Ivan C Gerling; Martha Campbell-Thompson; Clive Wasserfall; Alberto Pugliese; Jeffrey A Longmate; Desmond A Schatz; Mark A Atkinson; John S Kaddis
Journal:  Pancreas       Date:  2017-02       Impact factor: 3.327

8.  RNase 1 genes from the family Sciuridae define a novel rodent ribonuclease cluster.

Authors:  Steven J Siegel; Caroline M Percopo; Kimberly D Dyer; Wei Zhao; V Louise Roth; John M Mercer; Helene F Rosenberg
Journal:  Mamm Genome       Date:  2009-09-22       Impact factor: 2.957

9.  Optimization of duplex stability and terminal asymmetry for shRNA design.

Authors:  Olga V Matveeva; Yibin Kang; Alexey N Spiridonov; Pål Saetrom; Vladimir A Nemtsov; Aleksey Y Ogurtsov; Yury D Nechipurenko; Svetlana A Shabalina
Journal:  PLoS One       Date:  2010-04-20       Impact factor: 3.240

10.  Extensive genetic variation in somatic human tissues.

Authors:  Maeve O'Huallachain; Konrad J Karczewski; Sherman M Weissman; Alexander Eckehart Urban; Michael P Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.